OXYGEN IS ESSENTIAL for maintaining cellular integrity and function. Paradoxically, oxygen is also required for the formation of superoxide anion (O 2 Ϫ ⅐), a major reactive oxygen species (ROS) implicated in a variety of disease processes, including hypertension, ischemia-reperfusion injury, inflammation, and diabetes mellitus (6) . Previous studies from our laboratory (26) and others (2, 10, 16) showed that the rat kidney has a unique oxygen-gradient profile with lower PO 2 in the medulla. Remarkably, the medulla normally functions on the verge of hypoxia, with PO 2 values between 10 and 20 mmHg. This may be related to three factors. First, oxygen is shunted in the kidney, likely from small arteries to adjacent small veins in the inner cortex, which results in lower O 2 delivery to the entire kidney. This is confirmed by several reports that PO 2 in the cortex is lower than the PO 2 in both the renal artery and renal vein of experimental animals (2, 10) . Second, O 2 is shunted between descending and ascending vasa recta in the medulla, thereby supplying the medullary tissue with a very low PO 2 (10) . Third, the renal concentrating and diluting functions in the medulla require high O 2 consumption to support active transport of sodium, further reducing PO 2 . The low levels of renal oxygenation are exacerbated by hypertension (26) and diabetes (16) . We showed that PO 2 is reduced by ϳ10 to 33 mmHg in the outer and to 19 mmHg in the inner cortex in spontaneous hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) rats (26) . However, it remains undetermined whether the low oxygenation is sufficient to regulate renal O 2 Ϫ ⅐ production. NADPH oxidase is the primary source of O 2 Ϫ ⅐ in the kidney under physiological conditions (9) . The induction of oxidative stress or overproduction of O 2 Ϫ ⅐ often depends on increased NADPH oxidase expression or activity. Renal NADPH oxidase is upregulated with a high-salt diet (9), ANG II infusion (26) , diabetes (5, 8) , and ischemia-reperfusion injury (7) . In many of these models, the role of concomitant hypoxia on the O 2 Ϫ ⅐ production is beginning to emerge. Several in vitro models have shown that NADH-dependent O 2 Ϫ ⅐ production decreases in coronary (13) or pulmonary arteries (15) or cardiomyocytes (14) when exposed to hypoxia (PO 2 : 8 -10 mmHg). Reoxygenation (160 mmHg) or reperfusion increases O 2 Ϫ ⅐ production compared with the prehypoxic period or to ischemic tissue. However, regulation of renal NADPH oxidase activity by O 2 remains unclear, as one report showed that NADH-dependent O 2 Ϫ ⅐ production is enhanced in rat cortical thick ascending limbs of Henle's loop exposed to hypoxia (PO 2 : 5-10 mmHg) (11) . Because the oxygen environment in the kidney is unique, with a marked hypoxic medulla in normal animals, O 2 may limit O 2 Ϫ ⅐ formation in this region of the normal kidney. Thus we determined whether NADPH-dependent O 2 Ϫ ⅐ production is altered during changes in the physiological range of PO 2 in the kidney.
We tested the hypothesis that the low PO 2 commonly found in the kidney limits NADPH-dependent O 2 Ϫ ⅐ production. Specifically, we studied real-time, in vitro NADPH-dependent O 2 Ϫ ⅐ production in kidney tissue and cultured cells in response to various O 2 concentrations.
METHODS

Preparation of the Kidney Homogenate
The protocol describing the use of animals in this study was approved by the Georgetown University Animal Care and Use Committee. Male adult rats (225-265 g) were anesthetized, and kidney tissue was prepared as described previously (9) . The right external jugular veins were cannulated and the abdominal cavity was opened through a midline incision. Kidneys were removed and perfused with an ice-cold, pH 7.4, PBS via the renal artery to wash out blood. The kidney was cleaned of connective tissues and immediately frozen in liquid nitrogen. The left ventricle was prepared similarly. All the tissues were kept at Ϫ80°C. After being thawed, the samples were placed on ice in test tubes containing PBS and homogenized. Thereafter, the homogenate was centrifuged at 3,000 rpm for 20 min. The supernatant was used to study NADPH-dependent O 2 Ϫ ⅐ production. Pilot studies showed that O 2 Ϫ ⅐ levels were similar in fresh and frozen tissue and thawed from tissue.
Preparation of the Cultured Cells
The cells used in this study were: rat proximal tubule cells (PT; kindly provided by Dr. U. Hopfer, Case Western Reserve University, Cleveland, OH), mouse inner medulla collecting duct (IMCD; provided by Dr. B. A. Stanton, Dartmouth Medical School, Hanover, NH), rat vascular smooth muscle cells (VSM; A-10 cell line, ATCC, Manassas, VA), and rat cardiomyocytes (CM; Cell Applications, San Diego, CA). The cells were grown and maintained at 37°C in humidified atmosphere of 5% CO 2, in media containing 10% fetal bovine serum and other supplements as per instructions. The cells were grown to 80% confluence and washed with PBS. Cells were dislodged with scraping in PBS. Each measurement used 1 ϫ 10 6 cells.
Measurement of Superoxide Production
Lucigenin (final concentration 5 M)-enhanced chemiluminescence was used to determine O 2 Ϫ ⅐ generation after adding excess NADPH (100 mM), the substrate for NADPH oxidase. This method is specifically designed to measure NADPH oxidase capacity. A tube chemiluminescence apparatus was custom-constructed to include a light-tight box and a photodetector (Electron Tubes, Rockaway, NJ). This configuration permits simultaneous gassing and photon counting of the sample, allowing for rapid switching between two different concentrations of O 2 while a constant airflow rate is maintained. The chemiluminescence signals were sampled at 100 Hz and recorded cumulatively every second after background adjustment. For the tissue samples, the final values, expressed as relative light units (RLU), were corrected for protein concentration determined by protein assay. The integration of peak values recorded continuously for Ն20 s was calculated for the final comparison.
In this preparation, we showed that tempol, a superoxide dismutase (SOD) mimetic or SOD, inhibited 90% of the NADPH-dependent signal (9, 25) . The signal was also reduced by 70% by apocynin (100 mM). However, because apocynin acts to prevent assembly of NADPH oxidase subunits, its effectiveness in this in vitro preparation is unclear. The addition of rotenone (100 M, a mitochondrial complex inhibitor; 95 Ϯ 4%) did not affect the NADPH-dependent signals in the kidney or culture cell preparations within the tested range of PO 2. The involvement of mitochondrial complex was further evaluated using succinate (100 M). The succinate-dependent signal from the kidney homogenate was less than 8% of the NADPHdependent signal. There was no detectable succinate-dependent signal in the cultured cell preparations. The addition of N -nitro-L-arginine methyl ester (100 mol) or tetrahydrobiopterin (10 mM) did not alter the basal O 2 Ϫ ⅐ production, suggesting the O 2 Ϫ ⅐ signal is not linked to nitric oxide synthase. O 2 Ϫ ⅐ was not formed by the addition of NADH or xanthine. Thus the lucigenin-enhanced, NADPH-dependent O 2 Ϫ ⅐ signals were almost exclusively generated by NADPH oxidase in the cells and kidney tissue.
Measurement of O 2 and Experimental Protocol
Oxygen tension was measured using a combination needle O2 electrode with internal reference (model 768 -20R, Diamond General Development, Ann Arbor, MI). Within the experimental range, PO 2 increased linearly with increasing concentrations of gassing O2 (r 2 ϭ 0.998, P Ͻ 0.0001). The airflow was set at a slow rate to minimize bubbling. When concentrations of O 2 were changed, equilibration was achieved within 90 s.
All the samples were gassed for 3 min with 0, 1, 2, 3, or 4% O 2 (2, 7, 14, 20, 29, or 76 mmHg PO2) before and after baseline gassing at 10% O2 measurement. We were unable to completely eliminate residual O2 in these preparations, as gassing with 0 O2 resulted in PO2 of ϳ2 mmHg. Subsequently, NADPH, NADH, or xanthine (100 M) was applied, and the response was allowed to reach a steady state.
Chemicals
Lucigenin (bis-N-methylacridinium nitrate), NADH, NADPH, succinate, rotenone, and apocynin were purchased from Sigma (St. Louis, MO). NADH oxidase (from bacillus) was obtained from Calbiochem (San Diego, CA). All the chemicals were dissolved in PBS.
Experimental Series Series 1. O 2 Ϫ ⅐ production was assessed in normotensive and hypertensive rats. RLU output was measured in homogenates of kidney and left ventricle after the addition of oxidase substrates, NADPH, NADH, or xanthine. The homogenates were gassed with 10% O 2.
Series 2. NADPH-dependent O 2 Ϫ ⅐ production in kidney homogenates from normotensive and hypertensive rats was measured by continuous RLU during exposure of kidney homogenates to 0, 1, 2, 3, or 4% O 2, before and after exposure to 10% O2.
Series 3. NADPH-dependent O 2 Ϫ ⅐ production in renal cells was assessed by RLU during exposure to 2% O2 before and after exposure to 10% O2.
Series 4. O2 sensitivity of NADH-stimulated O 2 Ϫ ⅐ generated by purified NADH oxidase was measured during exposure to 0, 1, 2, 3, or 4% O 2 followed by 10% O2.
Data Processing and Statistical Analysis
Data are reported as means Ϯ SE. The chemiluminescence signals at various PO 2 were calculated as relative changes to their levels at PO2 ϭ 76 mmHg (gassing with 10% O2) for further comparison. Nonlinear regression or t-test was used to compare the changes in fluorescent intensity in response to changing PO 2. The results were considered significant at P Յ 0.05.
RESULTS
Series 1
The addition of NADPH to homogenates of rat kidney tissue generated high levels of O 2 Ϫ ⅐, whereas the addition of NADH or xanthine had minimal effects (Fig. 1) . Although we previously performed experiments to identify the source of O 2 Ϫ ⅐, these data provide the best evidence NADPH oxidase is the exclusive source in this preparation. NADPH-dependent O 2 Ϫ ⅐ production was also found in the rat left ventricle. The NADPH-dependent O 2 Ϫ ⅐ production was higher in hypertensive kidneys (P Ͻ 0.05), but not in hypertensive left ventricles. These data confirm that the major oxidative enzyme in these kidney and heart preparations is NADPH oxidase, which is increased in hypertensive kidneys.
Series 2
NADPH-initiated O 2 Ϫ ⅐ production was reduced when equilibrated with lower PO 2 levels. A representative experiment is shown in Fig. 2 . RLU was increased within seconds of switching the O 2 of the reaction mixture from 2 to 10%. This response was reversible. Regression analysis of data from exposure to 0, 1, 2, 3, 4, and 10% O 2 showed that the relative renal NADPHdependent O 2 Ϫ ⅐ production fell exponentially with O 2 levels below 4% (Fig. 3) . Although the basal activity levels were higher in hypertensive kidneys, there was no difference between the responses in tissue from normotensive and hypertensive rats (n ϭ 3 per group). The K m values were 15.4 Ϯ 1.3 and 13.9 Ϯ 2.9 mmHg PO 2 for the normotensive and hypertensive, respectively (not significant).
Series 3
Similar dependency of the NADPH-dependent O 2 Ϫ ⅐ production on O 2 levels was observed in cultured cells. As shown in Fig. 4 , the NADPH-dependent O 2 Ϫ ⅐ production decreased in the PT (Ϫ56.8 Ϯ 0.2%), IMCD (Ϫ57.9 Ϯ 2.6%), VSM (Ϫ42.1 Ϯ 4.5%), and CM (Ϫ56.8 Ϯ 1.1%) when these cells were exposed to 2% O 2 compared with 10% O 2 (P Ͻ 0.01, n ϭ 3 each cell type).
Series 4
We further examined the in vitro PO 2 effects using purified NADH oxidase in place of tissue or cells (3). NADH-initiated O 2 Ϫ ⅐ production by NADH oxidase decreased exponentially with decreasing PO 2 especially below ϳ30 mmHg (Fig. 5) NADPH oxidase as characterized in neutrophils is a complex enzyme consisting of five subunits: cytosolic p47 phox , p67 phox , p40 phox , and membrane bound ␣-and ␤-subunits, p22 phox and gp91 phox (2) . Tissue NADPH oxidases are not as well characterized, and although similar, homologs to the flavoprotein gp91 phox and to p47 phox and p67 phox have been identified. Various studies suggest that p22 phox and the flavoproteins are essential for NADPH oxidase function.
NADPH oxidase activity in increased in hypoxia/reperfusion injury in lungs and heart compared with prehypoxic conditions (4, 13-15, 17, 24, 27) . However, when measured during the hypoxic (PO 2 ϭ 8 -10 mmHg) phase of these studies, NADHstimulated O 2 Ϫ ⅐ production was reduced in coronary or pulmonary arteries and abolished in CM compared with basal (PO 2 ϭ 160 mmHg) (13) (14) (15) . These results are consistent with our observation that NADPH oxidase activity is limited by low O 2 .
The reduced O 2 Ϫ ⅐ production during hypoxia is not associated with a decrease in NADPH oxidase expression. In cultured endothelial cells exposed to 8 h of hypoxia, O 2 Ϫ ⅐ production was reduced, but expression for p22 phox was unchanged (20) . Studies in the kidney confirm that NADPH oxidase activity is limited by hypoxia. Oxidative stress, assessed by glutathione oxidation after 24 h, was not altered in kidneys of hypoxic mice despite upregulation of the ␤-subunit NOX-4 (22) . Therefore, O 2 Ϫ ⅐ production is limited by the availability of O 2 not the amount of enzyme.
However, O 2 Ϫ ⅐ production by NADPH oxidase may increase during hypoxia. Acute exposure of cultured smooth muscle cells from small bovine pulmonary arteries to moderate hypoxia (PO 2 Ϸ 40 mmHg) increased O 2 Ϫ ⅐ production, which was blocked by the NADPH oxidase inhibitor diphenyliodonium (DPI) but not by the mitochondrial inhibitor myxothiazol (12) . Also, anoxia generates a burst of ROS in cultured endothelial cells from porcine aorta that is blocked by DPI and by mitoQ, an inhibitor to mitochondrial ROS (18 (14) . Third, there may be differences in tissue responses, suggesting that the level of hypoxia and responses to hypoxia may differ in pulmonary, coronary, and renal vessels. However, we detected a rather uniform effect in renal, vascular, and cardiac cells when measured in vitro.
Our results confirm that NADPH oxidase is the dominant source for O 2 Ϫ ⅐ in the kidney in normal and hypertensive rats (9, 26) and that NADPH-dependent O 2 Ϫ ⅐ production is increased in hypertensive kidneys. However, an effect of hypertension on NADPH-dependent O 2 Ϫ ⅐ production was not seen in the heart. This observation needs further investigation. The absence of NADH-or xanthine-stimulated O 2 Ϫ ⅐ in both the kidney and heart confirms that the dominant oxidase in these tissues is NADPH oxidase. Some studies have shown that the NADH pathway is a greater source than the NADPH pathway for O 2 Ϫ ⅐ generation in the kidney (11) and cardiovascular system (13, 14) . Both the NADH (11) and NADPH (9) oxidases have been identified in the kidney. They have similar membrane and cytosolic components and are able to use both NADH and NADPH as substrates, depending on the availability of cofactors. The addition of FAD to the purified NADH oxidase used in this study limits this enzyme activity to NADH, as FAD prevents the oxidation of NADPH. Therefore, in vitro estimation of O 2 Ϫ ⅐ production depends critically on the availability of necessary cofactors, which was carefully controlled in these studies.
The availability of substrate may also be a rate-limiting process in vivo. Our measurements were made in the presence of saturating levels of substrates. The primary in vivo source for NADPH is from glucose metabolism through the pentose capacitation pathway. Glucose 6-phosphate is converted into ribulose 5-phosphate and CO 2 , leading to the synthesis of NADPH. The NADPH supply is low during oxidative stress (1, 19) or hypoxic conditions (23) . Therefore, when oxidase expression is increased especially in hypertension and diabetes, NADPH availability could also limit O 2 Ϫ ⅐ production (5, 21) . Although the total NADPH oxidase activity was higher in hypertensive rats, the sensitivity of the enzyme was similar in tissue from normotensive and hypertensive rats. This greater basal production of O 2 Ϫ ⅐ is due to the increased expression of NADPH oxidase mRNA and protein in hypertensive kidneys (6, 9) . However, the sensitivity differences to the level of O 2 may be a defense mechanism to avoid even greater oxidative stress. As we showed previously, the reduced renal PO 2 in hypertension may be due to the reduced efficiency of O 2 usage relative to sodium transport (26) . Thus the reduced PO 2 would limit O 2 Ϫ ⅐ production by NADPH oxidase and reduce the damage caused by oxidative stress in the kidney.
Because we show the same sensitivity of NADPH oxidase to PO 2 in kidneys from normotensive and hypertensive rats, this suggests that the different level of O 2 Ϫ ⅐ at baseline under normal oxygen (Fig. 1) could be due to enhanced NADPH oxidase expression and perhaps also to substrate or cofactor availability. However, a more plausible explanation may be related to the reduced O 2 availability in hypertensive rat kidneys. We showed that outer and inner cortical PO 2 were reduced to 32 and 22 mmHg, respectively, in hypertensive kidneys (26) . Under these conditions, NADPH oxidase activity may be suppressed sufficiently to limit the damage caused by oxidative stress in the kidney. However, when extracted and exposed to similar O 2 levels, the enzyme is equally active.
Superoxide production by NADPH oxidase in harvested renal tissue and cultured cells is reduced at O 2 levels below 4% (Յ30 mmHg). This is similar to the activity profile of purified NADH oxidase. Whereas the reduced PO 2 levels observed in the renal medulla may not prohibit oxidative stress associated with hypertension or diabetes, it may nevertheless limit O 2 Ϫ ⅐ production and its consequences. Therefore, low O 2 availability may be protective against oxidative stress in the renal medulla of normal rats. In addition, during hypertension or diabetes when PO 2 levels throughout the kidney are reduced, a protective role of low O 2 may extend into the cortex and ultimately reduce the tissue damage and other consequences of oxidative stress.
